{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T15:41:46Z","timestamp":1791042106813,"version":"4.1.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T00:00:00Z","timestamp":1558483200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T00:00:00Z","timestamp":1558483200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81672564"],"award-info":[{"award-number":["81672564"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Metastasis"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1007\/s10585-019-09971-4","type":"journal-article","created":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T20:19:02Z","timestamp":1558556342000},"page":"351-363","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["CTHRC1 promotes M2-like macrophage recruitment and myometrial invasion in endometrial carcinoma by integrin-Akt signaling pathway"],"prefix":"10.1007","volume":"36","author":[{"given":"Lu-Ying","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke-Min","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Han","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Gang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Di","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,5,22]]},"reference":[{"issue":"5","key":"9971_CR1","doi-asserted-by":"publisher","first-page":"E359","DOI":"10.1002\/ijc.29210","volume":"136","author":"J Ferlay","year":"2015","unstructured":"Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136(5):E359\u2013E386. \n                    https:\/\/doi.org\/10.1002\/ijc.29210","journal-title":"Int J Cancer"},{"issue":"9","key":"9971_CR2","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1038\/bjc.2011.68","volume":"104","author":"T Evans","year":"2011","unstructured":"Evans T, Sany O, Pearmain P, Ganesan R, Blann A, Sundar S (2011) Differential trends in the rising incidence of endometrial cancer by type: data from a UK population-based registry from 1994 to 2006. Br J Cancer 104(9):1505\u20131510. \n                    https:\/\/doi.org\/10.1038\/bjc.2011.68","journal-title":"Br J Cancer"},{"issue":"2","key":"9971_CR3","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3322\/caac.21262","volume":"65","author":"LA Torre","year":"2015","unstructured":"Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A (2015) Global cancer statistics, 2012. CA Cancer J Clin 65(2):87\u2013108. \n                    https:\/\/doi.org\/10.3322\/caac.21262","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"9971_CR4","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3322\/caac.21338","volume":"66","author":"W Chen","year":"2016","unstructured":"Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, Jemal A, Yu XQ, He J (2016) Cancer statistics in China, 2015. CA Cancer J Clin 66(2):115\u2013132. \n                    https:\/\/doi.org\/10.3322\/caac.21338","journal-title":"CA Cancer J Clin"},{"key":"9971_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2018.05.015","author":"RC Arend","year":"2018","unstructured":"Arend RC, Jones BA, Martinez A, Goodfellow P (2018) Endometrial cancer: molecular markers and management of advanced stage disease. Gynecol Oncol. \n                    https:\/\/doi.org\/10.1016\/j.ygyno.2018.05.015","journal-title":"Gynecol Oncol"},{"issue":"2","key":"9971_CR6","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.cll.2018.02.007","volume":"38","author":"E Abdulfatah","year":"2018","unstructured":"Abdulfatah E, Ahmed Q, Alosh B, Bandyopadhyay S, Bluth MH, Ali-Fehmi R (2018) Gynecologic cancers: molecular updates 2018. Clin Lab Med 38(2):421\u2013438. \n                    https:\/\/doi.org\/10.1016\/j.cll.2018.02.007","journal-title":"Clin Lab Med"},{"issue":"2","key":"9971_CR7","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.ygyno.2014.08.028","volume":"135","author":"K Kubler","year":"2014","unstructured":"Kubler K, Ayub TH, Weber SK, Zivanovic O, Abramian A, Keyver-Paik MD, Mallmann MR, Kaiser C, Serce NB, Kuhn W, Rudlowski C (2014) Prognostic significance of tumor-associated macrophages in endometrial adenocarcinoma. Gynecol Oncol 135(2):176\u2013183. \n                    https:\/\/doi.org\/10.1016\/j.ygyno.2014.08.028","journal-title":"Gynecol Oncol"},{"issue":"11","key":"9971_CR8","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1097\/PAS.0b013e3181f32168","volume":"34","author":"I Espinosa","year":"2010","unstructured":"Espinosa I, Jose Carnicer M, Catasus L, Canet B, D\u2019Angelo E, Zannoni GF, Prat J (2010) Myometrial invasion and lymph node metastasis in endometrioid carcinomas: tumor-associated macrophages, microvessel density, and HIF1A have a crucial role. Am J Surg Pathol 34(11):1708\u20131714. \n                    https:\/\/doi.org\/10.1097\/PAS.0b013e3181f32168","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"9971_CR9","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.ygyno.2007.12.033","volume":"109","author":"S Soeda","year":"2008","unstructured":"Soeda S, Nakamura N, Ozeki T, Nishiyama H, Hojo H, Yamada H, Abe M, Sato A (2008) Tumor-associated macrophages correlate with vascular space invasion and myometrial invasion in endometrial carcinoma. Gynecol Oncol 109(1):122\u2013128. \n                    https:\/\/doi.org\/10.1016\/j.ygyno.2007.12.033","journal-title":"Gynecol Oncol"},{"issue":"1","key":"9971_CR10","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.canlet.2016.03.036","volume":"376","author":"H Tong","year":"2016","unstructured":"Tong H, Ke JQ, Jiang FZ, Wang XJ, Wang FY, Li YR, Lu W, Wan XP (2016) Tumor-associated macrophage-derived CXCL8 could induce ERalpha suppression via HOXB13 in endometrial cancer. Cancer Lett 376(1):127\u2013136. \n                    https:\/\/doi.org\/10.1016\/j.canlet.2016.03.036","journal-title":"Cancer Lett"},{"issue":"Pt B","key":"9971_CR11","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.addr.2015.11.009","volume":"99","author":"Y Komohara","year":"2016","unstructured":"Komohara Y, Fujiwara Y, Ohnishi K, Takeya M (2016) Tumor-associated macrophages: Potential therapeutic targets for anti-cancer therapy. Adv Drug Deliv Rev 99(Pt B):180\u2013185. \n                    https:\/\/doi.org\/10.1016\/j.addr.2015.11.009","journal-title":"Adv Drug Deliv Rev"},{"issue":"4","key":"9971_CR12","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.it.2015.02.004","volume":"36","author":"R Ostuni","year":"2015","unstructured":"Ostuni R, Kratochvill F, Murray PJ, Natoli G (2015) Macrophages and cancer: from mechanisms to therapeutic implications. Trends Immunol 36(4):229\u2013239. \n                    https:\/\/doi.org\/10.1016\/j.it.2015.02.004","journal-title":"Trends Immunol"},{"issue":"1","key":"9971_CR13","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.cell.2010.03.014","volume":"141","author":"BZ Qian","year":"2010","unstructured":"Qian BZ, Pollard JW (2010) Macrophage diversity enhances tumor progression and metastasis. Cell 141(1):39\u201351. \n                    https:\/\/doi.org\/10.1016\/j.cell.2010.03.014","journal-title":"Cell"},{"issue":"6C","key":"9971_CR14","first-page":"4853","volume":"20","author":"I Hashimoto","year":"2000","unstructured":"Hashimoto I, Kodama J, Seki N, Hongo A, Miyagi Y, Yoshinouchi M, Kudo T (2000) Macrophage infiltration and angiogenesis in endometrial cancer. Anticancer Res 20(6C):4853\u20134856","journal-title":"Anticancer Res"},{"issue":"5","key":"9971_CR15","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1002\/(SICI)1097-0215(19991022)84:5<538::AID-IJC17>3.0.CO;2-B","volume":"84","author":"HB Salvesen","year":"1999","unstructured":"Salvesen HB, Akslen LA (1999) Significance of tumour-associated macrophages, vascular endothelial growth factor and thrombospondin-1 expression for tumour angiogenesis and prognosis in endometrial carcinomas. Int J Cancer 84(5):538\u2013543","journal-title":"Int J Cancer"},{"issue":"2","key":"9971_CR16","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1161\/01.RES.0000154262.07264.12","volume":"96","author":"P Pyagay","year":"2005","unstructured":"Pyagay P, Heroult M, Wang Q, Lehnert W, Belden J, Liaw L, Friesel RE, Lindner V (2005) Collagen triple helix repeat containing 1, a novel secreted protein in injured and diseased arteries, inhibits collagen expression and promotes cell migration. Circ Res 96(2):261\u2013268. \n                    https:\/\/doi.org\/10.1161\/01.RES.0000154262.07264.12","journal-title":"Circ Res"},{"issue":"3","key":"9971_CR17","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.neo.2014.03.001","volume":"16","author":"MZ Ma","year":"2014","unstructured":"Ma MZ, Zhuang C, Yang XM, Zhang ZZ, Ma H, Zhang WM, You H, Qin W, Gu J, Yang S, Cao H, Zhang ZG (2014) CTHRC1 acts as a prognostic factor and promotes invasiveness of gastrointestinal stromal tumors by activating Wnt\/PCP-Rho signaling. Neoplasia 16(3):265\u2013278. \n                    https:\/\/doi.org\/10.1016\/j.neo.2014.03.001\n                    \n                  \n                           278 e261\u2013213","journal-title":"Neoplasia"},{"issue":"4","key":"9971_CR18","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1007\/s12253-013-9636-y","volume":"19","author":"JH Kim","year":"2013","unstructured":"Kim JH, Baek TH, Yim HS, Kim KH, Jeong SH, Kang HB, Oh SS, Lee HG, Kim JW, Kim KD (2013) Collagen triple helix repeat containing-1 (CTHRC1) expression in invasive ductal carcinoma of the breast: the impact on prognosis and correlation to clinicopathologic features. Pathol Oncol Res 19(4):731\u2013737. \n                    https:\/\/doi.org\/10.1007\/s12253-013-9636-y","journal-title":"Pathol Oncol Res"},{"issue":"1","key":"9971_CR19","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s13048-017-0358-8","volume":"10","author":"B Guo","year":"2017","unstructured":"Guo B, Yan H, Li L, Yin K, Ji F, Zhang S (2017) Collagen triple helix repeat containing 1 (CTHRC1) activates Integrin beta3\/FAK signaling and promotes metastasis in ovarian cancer. J Ovarian Res 10(1):69. \n                    https:\/\/doi.org\/10.1186\/s13048-017-0358-8","journal-title":"J Ovarian Res"},{"issue":"3","key":"9971_CR20","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1093\/carcin\/bgs378","volume":"34","author":"EH Park","year":"2013","unstructured":"Park EH, Kim S, Jo JY, Kim SJ, Hwang Y, Kim JM, Song SY, Lee DK, Koh SS (2013) Collagen triple helix repeat containing-1 promotes pancreatic cancer progression by regulating migration and adhesion of tumor cells. Carcinogenesis 34(3):694\u2013702. \n                    https:\/\/doi.org\/10.1093\/carcin\/bgs378","journal-title":"Carcinogenesis"},{"key":"9971_CR21","first-page":"221","volume":"02","author":"CC Feng","year":"2017","unstructured":"Feng CC, Zhou Q, Xu FL, Guang Y (2017) Expression and clinical significance of CTHRC1 in endometrial cancer. Pract J Cancer 02:221\u2013223","journal-title":"Pract J Cancer"},{"issue":"1","key":"9971_CR22","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/0003-2697(84)90782-6","volume":"138","author":"D Wessel","year":"1984","unstructured":"Wessel D, Fl\u00fcgge UI (1984) A method for the quantitative recovery of protein in dilute solution in the presence of detergents and lipids. Anal Biochem 138(1):141\u2013143. \n                    https:\/\/doi.org\/10.1016\/0003-2697(84)90782-6","journal-title":"Anal Biochem"},{"issue":"9","key":"9971_CR23","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.1158\/0008-5472.CAN-17-2867","volume":"78","author":"YL Zhang","year":"2018","unstructured":"Zhang YL, Li Q, Yang XM, Fang F, Li J, Wang YH, Yang Q, Zhu L, Nie HZ, Zhang XL, Feng MX, Jiang SH, Tian GA, Hu LP, Lee HY, Lee SJ, Xia Q, Zhang ZG (2018) SPON2 promotes M1-like macrophage recruitment and inhibits hepatocellular carcinoma metastasis by distinct integrin-Rho GTPase-hippo pathways. Cancer Res 78(9):2305\u20132317. \n                    https:\/\/doi.org\/10.1158\/0008-5472.CAN-17-2867","journal-title":"Cancer Res"},{"issue":"3","key":"9971_CR24","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1161\/ATVBAHA.111.237412","volume":"32","author":"GE White","year":"2012","unstructured":"White GE, Greaves DR (2012) Fractalkine: a survivor\u2019s guide: chemokines as antiapoptotic mediators. Arterioscler Thromb Vasc Biol 32(3):589\u2013594. \n                    https:\/\/doi.org\/10.1161\/ATVBAHA.111.237412","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"34","key":"9971_CR25","doi-asserted-by":"publisher","first-page":"3875","DOI":"10.1038\/onc.2011.549","volume":"31","author":"D Balli","year":"2012","unstructured":"Balli D, Ren X, Chou FS, Cross E, Zhang Y, Kalinichenko VV, Kalin TV (2012) Foxm1 transcription factor is required for macrophage migration during lung inflammation and tumor formation. Oncogene 31(34):3875\u20133888. \n                    https:\/\/doi.org\/10.1038\/onc.2011.549","journal-title":"Oncogene"},{"issue":"1","key":"9971_CR26","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21442","volume":"68","author":"RL Siegel","year":"2018","unstructured":"Siegel RL, Miller KD, Jemal A (2018) Cancer statistics, 2018. CA Cancer J Clin 68(1):7\u201330. \n                    https:\/\/doi.org\/10.3322\/caac.21442","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"9971_CR27","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.clon.2008.04.005","volume":"20","author":"L Brown","year":"2008","unstructured":"Brown L (2008) Pathology of uterine malignancies. Clin Oncol 20(6):433\u2013447. \n                    https:\/\/doi.org\/10.1016\/j.clon.2008.04.005","journal-title":"Clin Oncol"},{"issue":"3","key":"9971_CR28","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1097\/PAP.0b013e31828d17cc","volume":"20","author":"AJ Cole","year":"2013","unstructured":"Cole AJ, Quick CM (2013) Patterns of myoinvasion in endometrial adenocarcinoma: recognition and implications. Adv Anat Pathol 20(3):141\u2013147. \n                    https:\/\/doi.org\/10.1097\/PAP.0b013e31828d17cc","journal-title":"Adv Anat Pathol"},{"issue":"7","key":"9971_CR29","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/nrclinonc.2016.217","volume":"14","author":"A Mantovani","year":"2017","unstructured":"Mantovani A, Marchesi F, Malesci A, Laghi L, Allavena P (2017) Tumour-associated macrophages as treatment targets in oncology. Nat Rev Clin Oncol 14(7):399\u2013416. \n                    https:\/\/doi.org\/10.1038\/nrclinonc.2016.217","journal-title":"Nat Rev Clin Oncol"},{"issue":"3","key":"9971_CR30","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.ccr.2013.02.013","volume":"23","author":"M De Palma","year":"2013","unstructured":"De Palma M, Lewis CE (2013) Macrophage regulation of tumor responses to anticancer therapies. Cancer Cell 23(3):277\u2013286. \n                    https:\/\/doi.org\/10.1016\/j.ccr.2013.02.013","journal-title":"Cancer Cell"},{"issue":"7","key":"9971_CR31","doi-asserted-by":"publisher","first-page":"2491","DOI":"10.1073\/pnas.1113744109","volume":"109","author":"V Cortez-Retamozo","year":"2012","unstructured":"Cortez-Retamozo V, Etzrodt M, Newton A, Rauch PJ, Chudnovskiy A, Berger C, Ryan RJ, Iwamoto Y, Marinelli B, Gorbatov R, Forghani R, Novobrantseva TI, Koteliansky V, Figueiredo JL, Chen JW, Anderson DG, Nahrendorf M, Swirski FK, Weissleder R, Pittet MJ (2012) Origins of tumor-associated macrophages and neutrophils. Proc Natl Acad Sci USA 109(7):2491\u20132496. \n                    https:\/\/doi.org\/10.1073\/pnas.1113744109","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"9971_CR32","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.immuni.2014.06.010","volume":"41","author":"R Noy","year":"2014","unstructured":"Noy R, Pollard JW (2014) Tumor-associated macrophages: from mechanisms to therapy. Immunity 41(1):49\u201361. \n                    https:\/\/doi.org\/10.1016\/j.immuni.2014.06.010","journal-title":"Immunity"},{"issue":"7355","key":"9971_CR33","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/nature10138","volume":"475","author":"BZ Qian","year":"2011","unstructured":"Qian BZ, Li J, Zhang H, Kitamura T, Zhang J, Campion LR, Kaiser EA, Snyder LA, Pollard JW (2011) CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis. Nature 475(7355):222\u2013225. \n                    https:\/\/doi.org\/10.1038\/nature10138","journal-title":"Nature"},{"key":"9971_CR34","doi-asserted-by":"publisher","first-page":"751392","DOI":"10.1155\/2014\/751392","volume":"2014","author":"J Zhou","year":"2014","unstructured":"Zhou J, Xiang Y, Yoshimura T, Chen K, Gong W, Huang J, Zhou Y, Yao X, Bian X, Wang JM (2014) The role of chemoattractant receptors in shaping the tumor microenvironment. Biomed Res Int 2014:751392. \n                    https:\/\/doi.org\/10.1155\/2014\/751392","journal-title":"Biomed Res Int"},{"issue":"10","key":"9971_CR35","doi-asserted-by":"publisher","first-page":"e47142","DOI":"10.1371\/journal.pone.0047142","volume":"7","author":"JP Stohn","year":"2012","unstructured":"Stohn JP, Perreault NG, Wang Q, Liaw L, Lindner V (2012) Cthrc1, a novel circulating hormone regulating metabolism. PLoS ONE 7(10):e47142. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0047142","journal-title":"PLoS ONE"},{"issue":"7","key":"9971_CR36","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1161\/ATVBAHA.108.166579","volume":"28","author":"RJ Leclair","year":"2008","unstructured":"Leclair RJ, Wang Q, Benson MA, Prudovsky I, Lindner V (2008) Intracellular localization of Cthrc1 characterizes differentiated smooth muscle. Arterioscler Thromb Vasc Biol 28(7):1332\u20131338. \n                    https:\/\/doi.org\/10.1161\/ATVBAHA.108.166579","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"9","key":"9971_CR37","doi-asserted-by":"publisher","first-page":"3914","DOI":"10.1172\/JCI69493","volume":"123","author":"S Takeshita","year":"2013","unstructured":"Takeshita S, Fumoto T, Matsuoka K, Park KA, Aburatani H, Kato S, Ito M, Ikeda K (2013) Osteoclast-secreted CTHRC1 in the coupling of bone resorption to formation. J Clin Invest 123(9):3914\u20133924. \n                    https:\/\/doi.org\/10.1172\/JCI69493","journal-title":"J Clin Invest"},{"issue":"19","key":"9971_CR38","doi-asserted-by":"publisher","first-page":"9410","DOI":"10.18632\/oncotarget.2421","volume":"5","author":"Z Ke","year":"2014","unstructured":"Ke Z, He W, Lai Y, Guo X, Chen S, Li S, Wang Y, Wang L (2014) Overexpression of collagen triple helix repeat containing 1 (CTHRC1) is associated with tumour aggressiveness and poor prognosis in human non-small cell lung cancer. Oncotarget 5(19):9410\u20139424. \n                    https:\/\/doi.org\/10.18632\/oncotarget.2421","journal-title":"Oncotarget"},{"issue":"8","key":"9971_CR39","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1038\/leu.2011.88","volume":"25","author":"E Ferretti","year":"2011","unstructured":"Ferretti E, Bertolotto M, Deaglio S, Tripodo C, Ribatti D, Audrito V, Blengio F, Matis S, Zupo S, Rossi D, Ottonello L, Gaidano G, Malavasi F, Pistoia V, Corcione A (2011) A novel role of the CX3CR39\/CX3CL1 system in the cross-talk between chronic lymphocytic leukemia cells and tumor microenvironment. Leukemia 25(8):1268\u20131277. \n                    https:\/\/doi.org\/10.1038\/leu.2011.88","journal-title":"Leukemia"},{"issue":"3","key":"9971_CR40","first-page":"233","volume":"3","author":"J Zhang","year":"2010","unstructured":"Zhang J, Patel JM (2010) Role of the CX3CL1-CX3CR40 axis in chronic inflammatory lung diseases. Int J Clin Exp Med 3(3):233\u2013244","journal-title":"Int J Clin Exp Med"},{"key":"9971_CR41","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/1742-2094-11-26","volume":"11","author":"Z Tang","year":"2014","unstructured":"Tang Z, Gan Y, Liu Q, Yin JX, Liu Q, Shi J, Shi FD (2014) CX3CR41 deficiency suppresses activation and neurotoxicity of microglia\/macrophage in experimental ischemic stroke. J Neuroinflamm 11:26. \n                    https:\/\/doi.org\/10.1186\/1742-2094-11-26","journal-title":"J Neuroinflamm"},{"issue":"3","key":"9971_CR42","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.jdermsci.2016.03.004","volume":"82","author":"S Morimura","year":"2016","unstructured":"Morimura S, Oka T, Sugaya M, Sato S (2016) CX3CR42 deficiency attenuates imiquimod-induced psoriasis-like skin inflammation with decreased M1 macrophages. J Dermatol Sci 82(3):175\u2013188. \n                    https:\/\/doi.org\/10.1016\/j.jdermsci.2016.03.004","journal-title":"J Dermatol Sci"},{"issue":"4","key":"9971_CR43","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1164\/rccm.201406-1137OC","volume":"191","author":"A Schmall","year":"2015","unstructured":"Schmall A, Al-Tamari HM, Herold S, Kampschulte M, Weigert A, Wietelmann A, Vipotnik N, Grimminger F, Seeger W, Pullamsetti SS, Savai R (2015) Macrophage and cancer cell cross-talk via CCR43 and CX3CR43 is a fundamental mechanism driving lung cancer. Am J Respir Crit Care Med 191(4):437\u2013447. \n                    https:\/\/doi.org\/10.1164\/rccm.201406-1137OC","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"9971_CR44","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1186\/gb-2007-8-5-215","volume":"8","author":"Y Takada","year":"2007","unstructured":"Takada Y, Ye X, Simon S (2007) The integrins. Genome Biol 8(5):215. \n                    https:\/\/doi.org\/10.1186\/gb-2007-8-5-215","journal-title":"Genome Biol"},{"issue":"6","key":"9971_CR45","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/S0092-8674(02)00971-6","volume":"110","author":"RO Hynes","year":"2002","unstructured":"Hynes RO (2002) Integrins: bidirectional, allosteric signaling machines. Cell 110(6):673\u2013687","journal-title":"Cell"},{"key":"9971_CR46","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.12688\/f1000research.11877.1","volume":"6","author":"W Longmate","year":"2017","unstructured":"Longmate W, DiPersio CM (2017) Beyond adhesion: emerging roles for integrins in control of the tumor microenvironment. F1000Res 6:1612. \n                    https:\/\/doi.org\/10.12688\/f1000research.11877.1","journal-title":"F1000Res"},{"issue":"1","key":"9971_CR47","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.ceb.2006.12.013","volume":"19","author":"I Delon","year":"2007","unstructured":"Delon I, Brown NH (2007) Integrins and the actin cytoskeleton. Curr Opin Cell Biol 19(1):43\u201350. \n                    https:\/\/doi.org\/10.1016\/j.ceb.2006.12.013","journal-title":"Curr Opin Cell Biol"},{"issue":"4","key":"9971_CR48","doi-asserted-by":"publisher","first-page":"E65","DOI":"10.1038\/ncb0402-e65","volume":"4","author":"MA Schwartz","year":"2002","unstructured":"Schwartz MA, Ginsberg MH (2002) Networks and crosstalk: integrin signalling spreads. Nat Cell Biol 4(4):E65\u2013E68. \n                    https:\/\/doi.org\/10.1038\/ncb0402-e65","journal-title":"Nat Cell Biol"},{"issue":"4","key":"9971_CR49","doi-asserted-by":"publisher","first-page":"299","DOI":"10.3233\/CBM-130352","volume":"13","author":"Y Zhang","year":"2013","unstructured":"Zhang Y, Yao X, Jiang C, Yue J, Guan J, Cheng H, Hajirashid M, Wang Y, Fan L (2013) Expression of PI3K, PTEN and Akt in small intestinal adenocarcinoma detected by quantum dots-based immunofluorescence technology. Cancer Biomark 13(4):299\u2013305. \n                    https:\/\/doi.org\/10.3233\/CBM-130352","journal-title":"Cancer Biomark"},{"issue":"6","key":"9971_CR50","doi-asserted-by":"publisher","first-page":"3637","DOI":"10.1007\/s13277-013-0945-2","volume":"34","author":"S Yothaisong","year":"2013","unstructured":"Yothaisong S, Dokduang H, Techasen A, Namwat N, Yongvanit P, Bhudhisawasdi V, Puapairoj A, Riggins GJ, Loilome W (2013) Increased activation of PI3K\/AKT signaling pathway is associated with cholangiocarcinoma metastasis and PI3K\/mTOR inhibition presents a possible therapeutic strategy. Tumor Biology 34(6):3637\u20133648. \n                    https:\/\/doi.org\/10.1007\/s13277-013-0945-2","journal-title":"Tumor Biology"},{"issue":"4","key":"9971_CR51","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1111\/j.1365-2567.2009.03181.x","volume":"129","author":"MV Ramos","year":"2010","unstructured":"Ramos MV, Fernandez GC, Brando RJ, Panek CA, Bentancor LV, Landoni VI, Isturiz MA, Palermo MS (2010) Interleukin-10 and interferon-gamma modulate surface expression of fractalkine-receptor (CX(3)CR51) via PI3K in monocytes. Immunology 129(4):600\u2013609. \n                    https:\/\/doi.org\/10.1111\/j.1365-2567.2009.03181.x","journal-title":"Immunology"}],"container-title":["Clinical &amp; Experimental Metastasis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10585-019-09971-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10585-019-09971-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10585-019-09971-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,20]],"date-time":"2020-05-20T19:09:44Z","timestamp":1590001784000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10585-019-09971-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,22]]},"references-count":51,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["9971"],"URL":"https:\/\/doi.org\/10.1007\/s10585-019-09971-4","relation":{},"ISSN":["0262-0898","1573-7276"],"issn-type":[{"value":"0262-0898","type":"print"},{"value":"1573-7276","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,22]]},"assertion":[{"value":"14 December 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no potential conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}